India, April 3 -- Sai Life Sciences Limited, an innovator-focusedContract Research, Development, and Manufacturing Organization (CRDMO), has inaugurated a dedicated Peptide Research Centre at its integrated R&D Campus in Hyderabad.

Announcing the launch,Krishna Kanumuri, CEO & Managing Director, Sai Life Sciences, said: "As the pharmaceutical industry evolves from small molecules to emerging modalities like peptides, we are expanding our capabilities to stay ahead. Our new Peptide Research Center reflects this commitment, designed to meet the growing demand for complex peptide synthesis and conjugation. With this investment, we reinforce our role as a trusted partner in advancing next-generation therapeutics."

The Peptide Research Centr...